APLS
Apellis Pharmaceuticals Inc
3.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.80 | 0.92 | 1.21 | 1.40 | 1.61 | 1.59 | 1.72 | 1.33 | 1.42 | 3.64 | 1.59 | 2.13 | 8.77 | |
| 0.07 | 0.19 | 0.16 | 0.17 | 0.19 | 0.27 | 0.33 | 0.27 | 0.11 | 0.19 | 0.24 | 0.32 | 0.87 | |
| 0.73 | 0.73 | 1.04 | 1.23 | 1.42 | 1.32 | 1.39 | 1.06 | 1.30 | 3.44 | 1.35 | 1.80 | 7.90 | |
| 0.80 | 0.66 | 0.57 | 0.69 | 0.63 | 0.71 | 0.62 | 0.69 | 0.53 | 0.54 | 0.59 | 0.61 | 2.27 | |
| 0.93 | 1.21 | 1.17 | 1.05 | 1.03 | 0.98 | 0.31 | 1.03 | 1.04 | 1.13 | 1.17 | 0.99 | 4.33 | |
| 1.74 | 1.87 | 1.74 | 1.74 | 1.66 | 1.70 | 1.60 | 1.72 | 1.57 | 1.67 | 1.76 | 1.60 | 6.60 | |
| -1.01 | -1.14 | -0.70 | -0.50 | -0.24 | -0.38 | -0.21 | -0.66 | -0.26 | 1.77 | -0.41 | 0.21 | 1.31 | |
| 0.06 | 0.06 | 0.06 | 0.06 | 0.08 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.35 | |
| -1.02 | -1.16 | -0.72 | -0.54 | -0.30 | -0.46 | -0.29 | -0.73 | -0.33 | 1.72 | -0.47 | 0.15 | 1.07 | |
| 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| -1.02 | -1.17 | -0.73 | -0.54 | -0.30 | -0.46 | -0.29 | -0.74 | -0.33 | 1.71 | -0.47 | 0.15 | 1.06 | |
| -0.96 | -1.10 | -0.65 | -0.48 | -0.22 | -0.35 | -0.19 | -0.64 | -0.24 | 1.81 | -0.38 | 0.24 | 1.43 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.